News
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...
13d
The Holy Mess on MSNGLP-1 Weight Loss Drugs: Miracle, Mess, or Something in Between?Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.
Although coverage restrictions remain in place, the trendiness of weight loss drugs may be creating a growing cost concern ...
The percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4% in 2019 to 15.7% in 2024.
A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results